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Since in the usual perfusion of isolated rat liver via the portal vein an insulin-dependent increase of hepatic 
glucose uptake could not be demonstrated, the possibility was considered that hepatic glucose uptake might 
not be a function of the absolute concentration of this substrate but of its concentration gradient between 
the portal vein and the hepatic artery. Therefore a new method was established for the simultaneous perfu- 
sion of isolated rat liver via both the hepatic artery (20-35s flow) and the portal vein (8&65% flow). When 
glucose was offered in a concentration gradient, 9.5 mM in the portal vein and 6 mM in the hepatic artery, 
insulin given via both vessels caused a shift from net glucose release to uptake. This insulin-dependent shift 
was not observed when glucose was offered without a gradient or with an inverse gradient, 6 mM in the 
portal vein and 9.5 mM in the hepatic artery. Using a portal-arterial glucose gradient as a signal the liver 
might be able to differentiate between endogenous and exogenous glucose. 
Glucose uptake Insulin 
1. INTRODUCTION 
The role of insulin in the regulation of hepatic 
carbohydrate metabolism is still a matter of 
debate. In isolated liver preparations such as cell 
cultures and liver perfusions many studies failed to 
demonstrate an effect of insulin on glucose 
balance, i.e. uptake or output [l-5]. Other in- 
vestigations howed a weak inhibitory effect of this 
hormone on basal glucose output [6-lo]. A more 
pronounced, antagonistic effect of insulin was 
observed after a glucagon-induced increase of 
glucose output [l l-141. Apparently an insulin- 
dependent net glucose uptake has never been 
demonstrated in isolated perfused liver. Even the 
perfusion of unphysiologically high glucose con- 
centrations failed to produce an increase of glucose 
uptake after the addition of insulin [14]. The 
reason for this lack of an insulin effect is not clear 
[ 151. A defect in isolated liver preparations has 
been proposed [lb]. 
(Perfused rat liver) 
The possibility was considered that the regula- 
tion of hepatic glucose metabolism might not be a 
function of the absolute concentration of this 
substrate but of a glucose concentration gradient 
between the portal vein and the hepatic artery. It 
was the aim of this investigation to examine this 
hypothesis. Therefore, a new method was 
established for the simultaneous perfusion of rat 
liver via the hepatic artery and the portal vein. It 
was found that a glucose gradient with a higher 
concentration in the portal vein is indeed an impor- 
tant signal for the insulin-dependent increase of 
net glucose uptake. By this mechanism the liver 
might be able to differentiate between endogenous 
and exogenous glucose. 
2. MATERIALS AND METHODS 
2.1. Materials 
All chemicals were of reagent grade and from 
commercial sources. Enzymes and bovine serum 
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albumin were purchased from Boehringer (D-6800 ponent via the portal vein (about 65-80% of flow) 
Mannheim). Insulin was from Serva (D-6900 and a ‘high-pressure’ component via the hepatic 
Heidelberg). artery (about 20-35% of flow). 
2.2. Animals 
Male Wistar rats (150-250 g) were obtained 
from Winkelmann (D-4791 Borchen). At least one 
week before the experiment hey were subjected to 
a 12 h day-night rhythm with free access to food 
(standard diet 1320 of Altromin, D-4937 Lage). All 
experiments were started at 9 a.m. The animals 
were anaesthetized by intraperitoneal injection of 
pentobarbital (60 mg/kg body wt). 
2.3. Liver perfusion 
The liver was perfused in situ without recircula- 
tion in a 37°C cabinet. At the beginning of the 
preparation open ligatures were positioned around 
5 different blood vessels: (a) the aorta cranial of 
the coeliac trunc, (b) the mesenterial artery, (c) the 
gastroduodenal artery, (d) the splenic vein and (e) 
the inferior caval vein (fig.1). The oesophagus and 
the hepatogastrical ligaments were cut in order to 
loosen the tight connection between liver and 
stomach. The ‘usual’ monovascular perfusion 
system via the portal vein was established by 
canulating this vessel and cutting the inferior caval 
vein open. At this stage liver perfusion via the por- 
tal vein was started at 10 mmHg with an 
erythrocyte-free Krebs-Henseleit-bicarbonate 
medium. Then the ligatures around the mesenterial 
artery (b), the splenic vein (d) and the 
gastroduodenal artery (c) were closed (fig.1). The 
aorta was canulated at the ramification of the aor- 
ta into the common iliacal arteries; the tip of the 
canula was pushed forward to the origin of the 
mesenterial artery. At this stage the additional per- 
fusion via the artery was begun at 120 mmHg with 
the medium described above. After closing the 
ligature around the aorta cranial of the coeliac 
trunc (a) the inferior caval vein was canulated and 
the canula of the aorta and the caval vein were 
sewed with the quadratus lumborum muscle and 
the sigmoidal section of the colon in order to avoid 
bleedings out of these two vessels. At this stage the 
perfusion medium was changed to an erythrocyte- 
containing medium. Thus a bivascular perfusion 
system was established with a ‘low-pressure’ com- 
The basic perfusion medium was a Krebs- 
Henseleit buffer containing 30% (v/v) bovine 
erythrocytes, 9.5 mM glucose, 2 mM lactate, 
0.2 mM pyruvate, 2 mM alanine, 1 mM glu- 
tamine, 2 mM ornithine, 0.2 mM ammonium 
chloride and 0.5% bovine serum albumin. In some 
experiments the glucose concentration was lowered 
to 6 mM as indicated in the figure legends. The 
medium was equilibrated with a gas mixture of 
13% (v/v) 02, 5% (v/v) CO2 and 82% (v/v) N2 
mimicking arterial tensions via both vessels. The 
effluent medium was collected after an initial 
period of 30 min and cooled on ice. Insulin was in- 
fused reaching final concentrations in the perfu- 
sion medium as indicated in the figures. Metab- 
olites were measured with standard enzymatic 
techniques, glucose with glucose dehydrogenase 
and lactate with lactate dehydrogenase [ 171. 
Fig. 1. Scheme of bivascular liver perfusion via the 
hepatic artery and the portal vein. For details ee text. 
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3. RESULTS 
3.1. Bivascular Iiver perfusion 
Rat livers were perfused in situ without recir- 
culation via the portal vein and the hepatic artery. 
Throughout the whole experiment he distribution 
of flow was held constant with a physiological por- 
tion of 20-35% for the hepatic artery. 
Physiological conditions were also simulated by 
establishing a high-pressure inflow (- 120 mmHg) 
via the hepatic artery and a low-pressure inflow via 
the portal vein (-10 mmHg). Although the hepatic 
artery was not directly canulated in this prepara- 
tion, bleedings via branching arteries were reliably 
prevented by ligating all these vessels. Alternative- 
ly in some preliminary experiments the common 
hepatic artery was directly canulated with a 
polyethylene tube. With this procedure only the 
gastroduodenal artery has to be ligated. Never- 
theless, the direct canulation has the important 
disadvantage of being more difficult and time con- 
suming because the hepatic artery is a nearly rec- 
tangular branching from the abdominal aorta and 
thus damaging of this vessel could only be 
prevented by very careful handling of the 
polyethylene tube. Therefore, this direct canula- 
tion seems to be only an alternative for rats with 
higher weight and correspondingly larger vessels. 
3.2. Influence of a portal-arterial glucose gradient 
on insulin-dependent glucose uptake 
As controls rat livers were perfused 
monovascularly only via the portal vein. The 
media contained substrates favouring glycogen 
synthesis [18]. In the presence of 10 mM glucose 
insulin provoked only a small decrease of glucose 
output (fig.2a). Similar experiments were per- 
formed with the bivascular perfusion technique. 
When 9.5 mM glucose was offered via both 
vessels, insulin added via both routes caused only 
a slight decrease of glucose output analogous to 
the effect in the monovascular perfusion (fig.2b). 
When, however, a glucose gradient was established 
with a high glucose concentration in the portal vein 
(9.5 mM) and a low concentration in the hepatic 
artery (6 mM), insulin infused via both vessels 
Por tovenous Portovenous-hepatic arterial Perfusion 
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Fig.2. Glucose and lactate balance in mono- and bivascular perfusions of rat liver. Glucose was supplied via the artery 
(a) and the portal vein (PO) in the concentrations indicated in the lower left inset in each panel. Insulin was infused 
when indicated at 100 nM via the portal vein (A) or via both the portal vein and the hepatic artery (B-D). Values are 
means f SE of 3 separate perfusions each. 
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caused a switch from glucose output to uptake 
(fig.2c). This continuous increase of glucose up- 
take was not completely finished even 20 min after 
the start of insulin infusion. 
When an inverse gradient of glucose with 6 mM 
in the portal vein and 9.5 mM in the hepatic artery 
was established, insulin did not cause a significant 
alteration of the glucose balance (fig.2d). Even the 
insulin-dependent reduction of glucose output as 
seen in perfusions without a glucose gradient 
(fig.aa,b) was not observed in the presence of an 
inverse glucose gradient. Therefore an insulin- 
dependent increase of glucose uptake was only 
demonstrable in isolated liver perfusion when a 
glucose concentration gradient between the portal 
vein and the hepatic artery (lower glucose levels) 
was established. 
Neither the conversion of the experimentai 
system to a bivascular perfusion nor the establish- 
ment of a glucose gradient between the portal vein 
and the hepatic artery influenced significantly the 
insulin-dependent alteration of the lactate balance 
(fig.2a-d). 
3.3. Influence of a portal-arterial insulin gradient 
on insulin-dependent glucose uptake 
It was examined further whether not only a 
glucose gradient but also an insulin gradient could 
act as a signal for the insulin-dependent alteration 
of glucose metabolism. When 9.5 mM glucose was 
supplied via both the portal vein and the hepatic 
artery, insulin infused with a gradient (the portal 
vein: 150 nM; hepatic artery: 30 nM) caused a 
switch from glucose output to uptake (not shown) 
similar though less pronounced as when a glucose 
gradient was offered. However, when both a 
glucose and an insulin gradient (only 2-fold; portal 
vein: 140 nM; hepatic artery: 70 nM) were 
established, no further increase of glucose uptake 
was observed (not shown). 
4. DISCUSSION 
4.1. Arterial-portal interactions 
The isolated liver perfused monovascularly via 
the portal vein has been for many years and still is 
an important experimental model for the study of 
liver metabolism. The model is eo ipso clearly un- 
physiological in one respect, it excludes possible 
contributions from the hepatic artery. This may be 
258 
acceptable at least for metabolic studies as long as 
one finds it difficult to envisage how a hepatocyte 
should differentiate in the mixed sinusoidal blood 
whether a substrate or hormone was delivered via 
the portal vein or via the artery. It might be less ac- 
ceptable also for metabolic investigations if one 
considers the possibility that different signals 
reaching the hepatocytes might be generated by 
substrates and hormones in the hepatic arterial and 
portal vascular tree. Indeed, for the regulation of 
liver hemodynamics arterial-portal interactions ap- 
pear to be well established [19], e.g. intraportal 
isoproterenol is without direct effect on portal 
flow but increases hepatic arterial flow almost to 
the same degree as intraarterial isoproterenol [20]. 
Such arterial-portal interactions may be important 
also for the regulation of liver metabolism. 
Therefore a perfusion system was established 
which allows the simultaneous perfusion of rat 
liver via the hepatic artery and the portal vein with 
physiological flow rates and pressures (fig.1). It 
could be shown with this system that a 
portovenous-arterial concentration gradient of 
glucose is an important signal for the insulin- 
dependent increase of glucose uptake (fig.2). Thus 
not only hemodynamic but also metabolic pro- 
cesses appear to be dependent on arterial- 
portovenous interactions. 
4.2. Mechanism of sensing arterial-portal 
concentration gradients 
The mechanism by which an arterial-portal gra- 
dient of glucose or any other substrate could be 
sensed and transmitted to the hepatocytes is totally 
unknown. A speculation may be based on the 
finding that afferent impulses from hypothetical 
hepatic glucose receptors ascend through afferent 
fibre of the vagus [21,22] and transmit glucose- 
related signals from the liver to the autonomic cen- 
tre of the hypothalamus, which in turn may con- 
trol via efferent fibres hepatic glucose metabolism. 
Thus it is conceivable that an intrahepatic nervous 
network ‘measures’ the glucose gradient and 
generates the appropriate signal within the liver to 
render the hepatocytes insulin-sensitive. 
4.3. Physiological significance of the portal- 
arterial glucose concentration gradient 
It is a widely held view that the liver in the 
postabsorptive situation supplies glucose if re- 
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quired by extrahepatic organs and that in the ab- 
sorptive phase it removes a substantial part of the 
excess glucose provided by a carbohydrate-rich 
meal. Thus normally the liver takes up only ex- 
ogenous glucose. A straightforward way to dif- 
ferentiate between endogenous and exogenous 
glucose would be to sense a portal-arterial glucose 
concentration gradient, since the portal concentra- 
tion will only be higher than the arterial one if 
glucose is absorbed from the gut at a high rate. The 
possible significance of portal-arterial glucose gra- 
dients for hepatic glucose uptake has also been in- 
dicated by preliminary reports on in vivo studies 
with dogs [23]. 
Recently, the view that the liver takes up 
glucose, e.g. mainly for glycogen synthesis, has 
been challenged; data have been presented showing 
that lactate rather than intact glucose is a major 
precursor of liver glycogen [24]. It was assumed 
that lactate was formed by the skeletal muscles, 
which however could not be corroborated by in 
vivo measurements [25,26]. An obvious way out of 
the dilemma is provided by the model of metabolic 
zonation [27-291 which postulates that the 
periportal hepatocytes hould synthesize glycogen 
from Cj substrates and that the perivenous cells 
should form it from glucose and at the same time 
convert glucose to lactate. Thus glucose uptake re- 
mains an essential function of the liver. 
The insulin-induced shift from hepatic glucose 
output to uptake, based on a portal-arterial 
glucose gradient, could be an important 
mechanism for the maintenance of glucose 
homeostasis. 
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